![](https://nocamels.com/wp-content/uploads/2013/12/IMG_0042-300x200.jpg)
Israel’s Evogene Tells NoCamels What It’s Like To Become A Major Public Company
Israeli companies are holding IPOs left and right. While the figures are usually all that hit the headlines, Israeli plant genomics company Evogene, which recently raised $84 million on the New York Stock Exchange, told NoCamels what it's really like to go public.
December 10, 2013